Paul Rennie
Patrimonio netto: 2 M $ in data 30/06/2026
Patrimonio netto: 2 M $ in data 30/06/2026
Paul John Rennie is the founder of Paradigm Biopharmaceuticals Ltd., where he currently holds the title of Executive Chairman & Managing Director.
Paradigm Biopharmaceuticals Ltd. was founded in 2014.
In addition to his founding position, Mr. Rennie has held former positions at Neuroscientific Biopharmaceuticals Ltd. as Non-Executive Chairman, Stiefel Research Australia Pty Ltd. as Director-Business Development, Merck KGaA as National Manager-Sales Marketing, Bonlac Foods Ltd. as Manager-Business Development, Mesoblast Ltd. as Executive Vice President-New Product Development, and Roche Diagnostics Australia Pty Ltd. as Manager-Sales & Marketing.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/06/2026 | 21.409.425 ( 3,66% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Amministratore Delegato | 22/11/2022 |
| Società | Posizione | Fine |
|---|---|---|
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Amministratore Delegato | 11/09/2023 |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Corporate Officer/Principal | - |
| MERCK KGAA | Vendite & Marketing | - |
Roche Diagnostics Australia Pty Ltd. | Vendite & Marketing | - |
| MESOBLAST LIMITED | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Bonlac Foods Ltd.
Bonlac Foods Ltd. Food DistributorsDistribution Services Manufactures dairy products and ingredients | Distribution Services |
Stiefel Research Australia Pty Ltd.
Stiefel Research Australia Pty Ltd. BiotechnologyHealth Technology Develops delivery systems for new dermatology products | Health Technology |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Roche Diagnostics Australia Pty Ltd. | |
Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale